Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Cardlytics Inc’s stock clocked out at $1.61, up 3.87% from its previous closing price of $1.55. In other words, the price has increased by $3.87 from its previous closing price. On the day, 0.59 million shares were traded. CDLX stock price reached its highest trading level at $1.67 during the session, while it also had its lowest trading level at $1.54.
Ratios:
To gain a deeper understanding of CDLX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.19 and its Current Ratio is at 1.19. In the meantime, Its Debt-to-Equity ratio is 3.17 whereas as Long-Term Debt/Eq ratio is at 2.48.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Evercore ISI on October 11, 2024, initiated with a In-line rating and assigned the stock a target price of $4.
On August 16, 2024, Northland Capital Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $5.
BofA Securities Downgraded its Neutral to Underperform on August 15, 2024, whereas the target price for the stock was revised from $4 to $3.50.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 22 ’25 when Lynton Nicholas Hollmeyer sold 303 shares for $1.51 per share. The transaction valued at 458 led to the insider holds 102,119 shares of the business.
Lynton Nicholas Hollmeyer bought 303 shares of CDLX for $458 on Apr 22 ’25. On Apr 02 ’25, another insider, Gupta Amit, who serves as the Chief Executive Officer of the company, sold 7,342 shares for $1.81 each. As a result, the insider received 13,260 and left with 371,080 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDLX now has a Market Capitalization of 84000944 and an Enterprise Value of 239914208. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.30 while its Price-to-Book (P/B) ratio in mrq is 1.18. Its current Enterprise Value per Revenue stands at 0.862 whereas that against EBITDA is -6.34.
Stock Price History:
The Beta on a monthly basis for CDLX is 1.31, which has changed by -0.86921203 over the last 52 weeks, in comparison to a change of 0.07545352 over the same period for the S&P500. Over the past 52 weeks, CDLX has reached a high of $15.89, while it has fallen to a 52-week low of $1.22. The 50-Day Moving Average of the stock is -25.31%, while the 200-Day Moving Average is calculated to be -57.44%.
Shares Statistics:
It appears that CDLX traded 1.01M shares on average per day over the past three months and 622770 shares per day over the past ten days. A total of 51.26M shares are outstanding, with a floating share count of 49.56M. Insiders hold about 5.01% of the company’s shares, while institutions hold 56.93% stake in the company. Shares short for CDLX as of 1743379200 were 8160778 with a Short Ratio of 8.10, compared to 1740700800 on 8984002. Therefore, it implies a Short% of Shares Outstanding of 8160778 and a Short% of Float of 18.290001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
